scPharmaceuticals Inc. (SCPH)
NASDAQ: SCPH · Real-Time Price · USD
5.26
-0.17 (-3.13%)
Sep 19, 2024, 4:00 PM EDT - Market closed
scPharmaceuticals Market Cap
scPharmaceuticals has a market cap or net worth of $263.15 million as of September 19, 2024. Its market cap has increased by 2.35% in one year.
Market Cap
263.15M
Enterprise Value
265.64M
1-Year Change
2.35%
Ranking
Category
Stock Price
$5.26
Market Cap Chart
Since November 17, 2017, scPharmaceuticals's market cap has increased from $248.30M to $263.15M, an increase of 5.98%. That is a compound annual growth rate of 0.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2024 | 271.70M | 20.86% |
| Dec 29, 2023 | 224.80M | 14.29% |
| Dec 30, 2022 | 196.70M | 43.26% |
| Dec 31, 2021 | 137.30M | -4.98% |
| Dec 31, 2020 | 144.50M | 36.97% |
| Dec 31, 2019 | 105.50M | 51.15% |
| Dec 31, 2018 | 69.80M | -67.21% |
| Dec 29, 2017 | 212.90M | -14.26% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vanda Pharmaceuticals | 271.05M |
| Black Diamond Therapeutics | 270.09M |
| Mersana Therapeutics | 268.66M |
| Rezolute | 266.82M |
| Zynex | 264.42M |
| Sera Prognostics | 260.28M |
| Biodesix | 258.42M |
| Adaptimmune Therapeutics | 258.30M |